AU6869574A - Antigenic modification of endogenous polypeptides - Google Patents

Antigenic modification of endogenous polypeptides

Info

Publication number
AU6869574A
AU6869574A AU68695/74A AU6869574A AU6869574A AU 6869574 A AU6869574 A AU 6869574A AU 68695/74 A AU68695/74 A AU 68695/74A AU 6869574 A AU6869574 A AU 6869574A AU 6869574 A AU6869574 A AU 6869574A
Authority
AU
Australia
Prior art keywords
endogenous polypeptides
antigenic modification
antigenic
modification
endogenous
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU68695/74A
Other versions
AU524925B2 (en
Inventor
C. Stevens Vernon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ohio State University
Original Assignee
Ohio State University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ohio State University filed Critical Ohio State University
Publication of AU6869574A publication Critical patent/AU6869574A/en
Application granted granted Critical
Publication of AU524925B2 publication Critical patent/AU524925B2/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0006—Contraceptive vaccins; Vaccines against sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/59—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/5555—Muramyl dipeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6012—Haptens, e.g. di- or trinitrophenyl (DNP, TNP)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Reproductive Health (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Virology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU68695/74A 1973-05-07 1974-05-07 Antigenic modification of endogenous polypeptides Expired AU524925B2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US35789273A 1973-05-07 1973-05-07
USUS357882 1973-05-07
US40682173A 1973-10-16 1973-10-16
USUS406821 1973-10-16

Publications (2)

Publication Number Publication Date
AU6869574A true AU6869574A (en) 1975-11-13
AU524925B2 AU524925B2 (en) 1982-10-14

Family

ID=26999834

Family Applications (1)

Application Number Title Priority Date Filing Date
AU68695/74A Expired AU524925B2 (en) 1973-05-07 1974-05-07 Antigenic modification of endogenous polypeptides

Country Status (17)

Country Link
JP (1) JPS623128B2 (en)
AT (1) AT356263B (en)
AU (1) AU524925B2 (en)
CA (1) CA1057742A (en)
CH (1) CH622426A5 (en)
DD (1) DD113919A5 (en)
DE (1) DE2421943A1 (en)
FR (1) FR2228477B1 (en)
GB (1) GB1473601A (en)
HK (1) HK41280A (en)
IE (1) IE42002B1 (en)
IL (1) IL44779A (en)
MY (1) MY8100128A (en)
NL (1) NL7406098A (en)
NZ (1) NZ174192A (en)
PL (1) PL97318B1 (en)
SE (1) SE7406096L (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU570004B2 (en) * 1983-03-04 1988-03-03 Ohio State University, The Antigenic modification of peptides

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1054937A (en) * 1975-01-28 1979-05-22 Gursaran P. Talwar Antipregnancy vaccine
FR2319379A1 (en) * 1975-07-29 1977-02-25 All India Inst Medical Scie Contraceptive vaccine for women - comprising a conjugate of tetanus anatoxin andhuman chlorionic gonadotrophin (3-sub-unit with no strong reaction with anti-LH serium)
JPS55160725A (en) * 1975-07-30 1980-12-13 Paashiyado Taruwaa Gaasaran Contraceptive vaccine and its manufacture
NZ182272A (en) * 1975-10-14 1985-03-20 Univ Ohio State Modified polypeptides for the immunological control of fertility,and pharmaceutical compositions
JPS5294416A (en) * 1976-01-24 1977-08-09 Paashiyado Taruwaa Gaasaran Vaccine for contraception and use of same
JPS5633907Y2 (en) * 1976-09-16 1981-08-11
US4096237A (en) * 1977-03-14 1978-06-20 Hoffmann-La Roche Inc. Immunoassay for β-endorphin
US4234561A (en) * 1978-02-06 1980-11-18 Research Corporation Antigen for early pregnancy test and contraceptive vaccine
US4310455A (en) * 1979-04-17 1982-01-12 Research Corporation Antigen for early pregnancy test and contraceptive vaccine
CA1239346A (en) * 1985-06-04 1988-07-19 Gursaran P. Talwar Birth control vaccine
FR2832066A1 (en) * 2001-11-14 2003-05-16 Agronomique Inst Nat Rech CONTRACEPTIVE VACCINE COMPOSITIONS COMPRISING A PEPTIDE OR A SET OF PEPTIDES ENCODED BY ALL OR PART OF EXON 1 OF AN FSH RECEPTOR

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA903671A (en) * 1972-06-27 J. Lewis Andrew Soluble cancer antigens coupled to foreign proteins
DE1467782A1 (en) * 1963-07-17 1968-12-12 Behringwerke Ag Process for the production of artificial antigens
US3317400A (en) * 1964-11-23 1967-05-02 Upjohn Co Enzymatic modification of bovine growth hormone by proteolytic streptomycete cell extracts
GB1393965A (en) * 1971-05-05 1975-05-14 Ortho Pharma Corp Vaccine and method for inducing infertility in a male animal

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU570004B2 (en) * 1983-03-04 1988-03-03 Ohio State University, The Antigenic modification of peptides
AU588448B2 (en) * 1983-03-04 1989-09-14 Ohio State University, The Zona pellucida or sperm antigens for fertility control

Also Published As

Publication number Publication date
JPS623128B2 (en) 1987-01-23
DE2421943A1 (en) 1974-11-28
IL44779A (en) 1977-10-31
MY8100128A (en) 1981-12-31
GB1473601A (en) 1977-05-18
CA1057742A (en) 1979-07-03
CH622426A5 (en) 1981-04-15
NL7406098A (en) 1974-11-11
FR2228477A1 (en) 1974-12-06
HK41280A (en) 1980-08-15
DE2421943C2 (en) 1989-10-26
FR2228477B1 (en) 1977-07-01
NZ174192A (en) 1985-02-28
ATA377074A (en) 1979-09-15
AU524925B2 (en) 1982-10-14
IE42002B1 (en) 1980-05-21
DD113919A5 (en) 1975-07-05
JPS5069221A (en) 1975-06-10
PL97318B1 (en) 1978-02-28
SE7406096L (en) 1975-01-31
IE42002L (en) 1974-11-07
IL44779A0 (en) 1974-07-31
AT356263B (en) 1980-04-25

Similar Documents

Publication Publication Date Title
AU498757B2 (en) Cyclization of peptides
CA1028341A (en) Preparation of n-phosphono methyl glycine
CA1024130A (en) Ceramic materials
AU524925B2 (en) Antigenic modification of endogenous polypeptides
CA1035792A (en) Preparation of 5-sec-alkyl-m-cresol
CA1029719A (en) Preparation of a-6-deoxy-5-hydroxytetracycline
CA1026680A (en) Antiperspirant stick
AU508018B2 (en) Polypeptide cosmetic preparation
CA1033741A (en) Derivatives of 4-hydroxy-5-azacoumarin
AU472316B2 (en) Improvements inthe forming of materials
CA1020945A (en) 2-benzimidazolethiol preparation
AU476488B2 (en) Preparation of 6-deoxytetracyclines
CA955933A (en) Preparation of peptides
CA1020300A (en) Adducts of polypentenamers
AU495192B2 (en) Dehydroformylation of acetoxybutyraldehydes
CA1025864A (en) Preparation of 2-amino-4-hydroxypyrimidines
CA1006393A (en) Curing of meats
AU484974B2 (en) Preparation of aromatics
AU486481B2 (en) Preparation of methylcobalamine
JPS5312819A (en) Preparation of nnsubstituted chloroacetoanilide
AU6952074A (en) Dehydroformylation of acetoxybutyraldehydes
AU7188674A (en) Preparation of methylcobalamine
AU482566B2 (en) Preparation of glycol acetates
CA1034947A (en) PREPARATION OF ALKYLTHIO-.alpha.-THIOLINCOSAMINIDES
CA1034946A (en) PREPARATION OF ALKYLTHIO-.alpha.-THIOLINCOSAMINIDES